Literature DB >> 23857044

Neurodegenerative disease: can synucleinopathy and tauopathy be identified during life?

Shin-ichiro Kubo, Nobutaka Hattori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23857044     DOI： 10.1038/nrneurol.2013.137

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.

Authors:  William T Hu; Gregory W Rippon; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Keith A Josephs
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 2.  Milestones in atypical and secondary Parkinsonisms.

Authors:  Gregor K Wenning; Irene Litvan; Eduardo Tolosa
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 3.  The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study.

Authors:  Bradley F Boeve
Journal:  J Mol Neurosci       Date:  2011-08-19       Impact factor: 3.444

4.  Cognitive and motor assessment in autopsy-proven corticobasal degeneration.

Authors:  R Murray; M Neumann; M S Forman; J Farmer; L Massimo; A Rice; B L Miller; J K Johnson; C M Clark; H I Hurtig; M L Gorno-Tempini; V M-Y Lee; J Q Trojanowski; M Grossman
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

Review 5.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

Review 6.  Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.

Authors:  Taku Hatano; Shin-ichiro Kubo; Shigeto Sato; Nobutaka Hattori
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

7.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

8.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

Authors:  A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; H I Hurtig; C M Clark; B L Miller; V M-Y Lee; J Q Trojanowski; M Grossman; V M Van Deerlin
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

Review 9.  Neuropathology of non-Alzheimer degenerative disorders.

Authors:  Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2009-08-25

10.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173
  10 in total
  1 in total

1.  Blood pressure fluctuation and hypertension in patients with Parkinson's disease.

Authors:  Tetsuro Tsukamoto; Yoshimi Kitano; Sadako Kuno
Journal:  Brain Behav       Date:  2013-10-11       Impact factor: 2.708
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.